Carr Douglas, Century Therapeutics’ SVP Finance & Operations, sold 254 shares at $2.05 per share on 2026-09-08. The transaction represented about 0.1% of Douglas’s prior shareholding, while his reported position after the sale was 504,565 shares, giving investors the disclosed scale of the executive ownership change.

Key Highlights

  • The filing reported SEC transaction code S for Carr Douglas’s sale.
  • Douglas held 504,565 Century Therapeutics shares after the transaction.
  • The sale represented about 0.1% of Douglas’s prior shareholding.

Carr Douglas, SVP Finance & Operations at Century Therapeutics, Inc. (NASDAQ: IPSC), sold 254 shares at $2.05 per share. The transaction occurred on 8 September 2026 and left Douglas holding 504,565 Century Therapeutics shares.

Sale Involves 254 Shares

Carr Douglas serves as Century Therapeutics’ SVP Finance & Operations. The filing reported SEC transaction code S for the trade. The disclosed price was measured per share, while the transaction size was 254 shares. After the sale, Douglas’s reported Century Therapeutics position stood at 504,565 shares. The transaction therefore involved a defined number of shares transferred at a stated per-share price.

Sale Equals About 0.1% of Prior Holding

The transaction represented about 0.1% of Douglas’s prior shareholding. That percentage measures the sale against the position held before the transaction. Transaction code S denotes an open-market or private sale.